Gland Pharma, 543245, GLAND Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

29,324.16
42.40
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

26,782.82
1.12%
3.34

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.41
16.56
8.78

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.11
6.89
-2.46

PAT CAGR (%)

10 Years
5 Years
3 Years

17.43
-0.01
-13.93

P:E (Median)

8 Years
5 Years
3 Years

-
-
38.25

P:BV (Average)

8 Years
5 Years
3 Years

-
-
4.22

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
-
20.28

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 46.9 48.63 64.63 73.9
P/E Ratio 36.85 35.54 26.74 23.39
Revenue 5642 6120 6888 7614
EBITDA 1333 1363 1682 1996
Net Income 772 822 1108 1311
ROA 8 7.5 9.6 10.9
P/Bk Ratio 3.26 3.01 2.73 2.46
ROE 9.26 9.02 10.93 11.45
FCFF 718.31 346.53 469.38 844.67
FCFF Yield 2.64 1.27 1.73 3.1

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 1,062.99 1,010.67 5.18% 1,012.02 884.07 14.47% 1,174.83 785.42 49.58% 1,097.86 925.90 18.57%
Expenses 699.19 663.57 5.37% 718.47 624.71 15.01% 742.00 616.27 20.40% 728.37 641.94 13.46%
EBITDA 363.80 347.10 4.81% 293.55 259.36 13.18% 432.83 169.15 155.89% 369.49 283.96 30.12%
EBIDTM 34.22% 34.34% 29.01% 29.34% 36.84% 21.54% 33.66% 30.67%
Other Income 57.80 41.11 40.60% 48.49 35.21 37.72% 46.95 38.94 20.57% 43.39 61.51 -29.46%
Interest 0.17 0.91 -81.32% 0.91 1.60 -43.12% 4.53 2.18 107.80% 0.80 2.62 -69.47%
Depreciation 41.61 40.24 3.40% 40.82 38.98 4.72% 42.56 37.54 13.37% 40.33 37.61 7.23%
PBT 379.82 347.06 9.44% 300.31 253.99 18.24% 432.69 111.91 286.64% 371.75 305.24 21.79%
Tax 98.11 89.54 9.57% 77.39 66.41 16.53% 111.28 32.70 240.31% 94.95 77.70 22.20%
PAT 281.71 257.53 9.39% 222.92 187.58 18.84% 321.41 79.21 305.77% 276.81 227.54 21.65%
PATM 26.50% 25.48% 22.03% 21.22% 27.36% 10.08% 25.21% 24.57%
EPS 17.09 15.63 9.34% 13.53 11.38 18.89% 19.50 4.81 305.41% 16.80 13.81 21.65%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 1,405.83 1,373.42 2.36% 1,401.71 1,208.69 15.97% 1,537.45 785.01 95.85% 1,545.15 938.29 64.68%
Expenses 1,108.78 1,049.35 5.66% 1,137.31 914.74 24.33% 1,178.80 616.59 91.18% 1,188.76 648.72 83.25%
EBITDA 297.06 324.08 -8.34% 264.40 293.95 -10.05% 358.65 168.42 112.95% 356.39 289.57 23.08%
EBIDTM 21.13% 23.60% 18.86% 24.32% 23.33% 21.45% 23.07% 30.86%
Other Income 59.66 53.15 12.25% 51.43 37.54 37.00% 42.15 38.94 8.24% 37.39 61.51 -39.21%
Interest 6.11 6.05 0.99% 5.62 4.92 14.23% 9.96 2.20 352.73% 5.28 2.62 101.53%
Depreciation 93.83 81.30 15.41% 91.96 65.31 40.81% 92.61 37.54 146.70% 105.34 37.61 180.09%
PBT 256.78 289.89 -11.42% 218.24 261.27 -16.47% 298.23 111.15 168.31% 283.16 310.85 -8.91%
Tax 93.25 95.81 -2.67% 74.48 67.16 10.90% 105.81 32.47 225.87% 91.30 78.90 15.72%
PAT 163.53 194.08 -15.74% 143.76 194.10 -25.94% 192.42 78.68 144.56% 191.86 231.95 -17.28%
PATM 11.63% 14.13% 10.26% 16.06% 12.52% 10.02% 12.42% 24.72%
EPS 9.93 11.78 -15.70% 8.73 11.79 -25.95% 11.68 4.78 144.35% 11.65 14.08 -17.26%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 4,347.70 4,167.43 3,616.53 4,400.71 3,462.88 2,633.24 2,044.20 1,619.94 1,479.18 1,347.87 993.80 Net Sales Growth 20.57% 15.23% -17.82% 27.08% 31.51% 28.82% 26.19% 9.52% 9.74% 35.63% Cost Of Goods Sold 1,953.98 1,820.31 1,685.42 2,109.22 1,219.00 836.07 626.35 479.75 375.07 540.21 414.04 Gross Profit 2,393.72 2,347.12 1,931.10 2,291.49 2,243.88 1,797.18 1,417.85 1,140.18 1,104.11 807.66 579.75 GP Margin 55.06% 56.32% 53.40% 52.07% 64.80% 68.25% 69.36% 70.38% 74.64% 59.92% 58.34% Total Expenditure 2,888.03 2,758.65 2,597.98 2,890.07 2,160.61 1,677.77 1,337.89 1,084.84 854.19 845.63 677.60 Power & Fuel Cost - 117.19 124.84 95.05 74.58 78.50 74.03 60.35 49.24 46.96 42.72 % Of Sales - 2.81% 3.45% 2.16% 2.15% 2.98% 3.62% 3.73% 3.33% 3.48% 4.30% Employee Cost - 409.94 399.70 338.57 311.36 277.66 222.95 179.08 153.42 131.30 105.69 % Of Sales - 9.84% 11.05% 7.69% 8.99% 10.54% 10.91% 11.05% 10.37% 9.74% 10.63% Manufacturing Exp. - 218.95 194.21 179.85 436.84 391.88 337.81 269.23 217.13 72.95 62.42 % Of Sales - 5.25% 5.37% 4.09% 12.61% 14.88% 16.53% 16.62% 14.68% 5.41% 6.28% General & Admin Exp. - 109.27 119.02 93.79 58.62 57.77 47.00 78.76 42.74 32.91 30.74 % Of Sales - 2.62% 3.29% 2.13% 1.69% 2.19% 2.30% 4.86% 2.89% 2.44% 3.09% Selling & Distn. Exp. - 34.66 30.26 40.98 36.69 17.08 13.88 9.93 11.40 15.80 16.41 % Of Sales - 0.83% 0.84% 0.93% 1.06% 0.65% 0.68% 0.61% 0.77% 1.17% 1.65% Miscellaneous Exp. - 48.31 44.53 32.61 23.51 18.82 15.86 7.73 5.19 5.52 16.41 % Of Sales - 1.16% 1.23% 0.74% 0.68% 0.71% 0.78% 0.48% 0.35% 0.41% 0.56% EBITDA 1,459.67 1,408.78 1,018.55 1,510.64 1,302.27 955.47 706.31 535.10 624.99 502.24 316.20 EBITDA Margin 33.57% 33.80% 28.16% 34.33% 37.61% 36.28% 34.55% 33.03% 42.25% 37.26% 31.82% Other Income 196.63 166.67 240.46 223.94 134.78 139.17 85.56 48.79 33.56 36.76 29.65 Interest 6.41 7.84 7.41 5.24 3.41 7.18 3.56 4.13 6.39 16.42 16.69 Depreciation 165.32 162.11 146.74 110.30 98.78 94.59 81.96 78.21 74.15 63.46 56.72 PBT 1,484.57 1,405.50 1,104.86 1,619.04 1,334.85 992.87 706.36 501.56 578.01 459.11 272.43 Tax 381.73 362.17 272.58 406.89 337.85 220.01 234.45 180.45 164.28 145.51 63.16 Tax Rate 25.71% 25.77% 26.00% 25.13% 25.31% 22.16% 34.16% 35.98% 28.42% 31.69% 23.18% PAT 1,102.85 1,043.33 775.83 1,212.15 997.00 772.86 451.91 321.11 413.73 313.61 209.27 PAT before Minority Interest 1,102.85 1,043.33 775.83 1,212.15 997.00 772.86 451.91 321.11 413.73 313.61 209.27 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 25.37% 25.04% 21.45% 27.54% 28.79% 29.35% 22.11% 19.82% 27.97% 23.27% 21.06% PAT Growth 46.68% 34.48% -36.00% 21.58% 29.00% 71.02% 40.73% -22.39% 31.93% 49.86% EPS 66.92 63.31 47.08 73.55 60.50 46.90 27.42 19.48 25.10 19.03 12.70

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Net Sales 5,890.14 5,664.72 3,624.60 4,400.71 3,462.88 2,633.24 Net Sales Growth 36.81% 56.29% -17.64% 27.08% 31.51% Cost Of Goods Sold 2,338.33 2,173.09 1,685.42 2,109.11 1,219.00 836.07 Gross Profit 3,551.81 3,491.63 1,939.17 2,291.60 2,243.88 1,797.18 GP Margin 60.30% 61.64% 53.50% 52.07% 64.80% 68.25% Total Expenditure 4,613.65 4,331.65 2,599.84 2,890.56 2,160.65 1,677.77 Power & Fuel Cost - 229.99 124.84 95.05 74.58 78.50 % Of Sales - 4.06% 3.44% 2.16% 2.15% 2.98% Employee Cost - 1,256.89 403.26 338.57 311.36 277.66 % Of Sales - 22.19% 11.13% 7.69% 8.99% 10.54% Manufacturing Exp. - 327.19 194.23 179.85 436.84 391.88 % Of Sales - 5.78% 5.36% 4.09% 12.61% 14.88% General & Admin Exp. - 217.36 120.53 94.28 58.66 57.77 % Of Sales - 3.84% 3.33% 2.14% 1.69% 2.19% Selling & Distn. Exp. - 37.46 27.03 40.98 36.69 17.08 % Of Sales - 0.66% 0.75% 0.93% 1.06% 0.65% Miscellaneous Exp. - 89.66 44.53 32.72 23.51 18.82 % Of Sales - 1.58% 1.23% 0.74% 0.68% 0.71% EBITDA 1,276.50 1,333.07 1,024.76 1,510.15 1,302.23 955.47 EBITDA Margin 21.67% 23.53% 28.27% 34.32% 37.61% 36.28% Other Income 190.63 170.24 240.46 223.94 134.78 139.17 Interest 26.97 26.20 7.45 5.24 3.41 7.18 Depreciation 383.74 344.57 146.74 110.30 98.78 94.59 PBT 1,056.41 1,132.54 1,111.04 1,618.55 1,334.81 992.87 Tax 364.84 360.08 273.54 406.89 337.85 220.01 Tax Rate 34.54% 31.79% 25.94% 25.14% 25.31% 22.16% PAT 691.57 772.46 781.04 1,211.66 996.96 772.86 PAT before Minority Interest 691.57 772.46 781.04 1,211.66 996.96 772.86 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.74% 13.64% 21.55% 27.53% 28.79% 29.35% PAT Growth -1.04% -1.10% -35.54% 21.54% 29.00% EPS 41.96 46.87 47.39 73.52 60.50 46.90

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 8,995.29 7,953.30 7,158.23 5,903.28 3,646.24 2,862.11 2,410.42 2,089.81 1,677.07 1,394.19 Share Capital 16.47 16.47 16.43 16.36 15.49 15.49 15.49 15.49 15.49 15.67 Total Reserves 8,977.43 7,935.16 7,128.56 5,861.51 3,614.26 2,846.62 2,394.93 2,074.32 1,661.57 1,378.52 Non-Current Liabilities 131.60 89.68 93.97 80.31 80.78 127.79 139.37 130.55 121.95 119.76 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 50.17 70.49 Unsecured Loans 2.55 3.26 3.82 3.93 4.07 4.96 5.49 5.92 6.37 6.67 Long Term Provisions 20.69 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Liabilities 414.20 730.20 581.94 512.46 359.02 532.68 378.55 253.38 287.29 244.18 Trade Payables 295.08 589.42 462.76 396.28 249.09 446.20 292.42 189.29 88.51 65.57 Other Current Liabilities 87.05 109.46 76.42 62.36 81.73 72.60 71.13 61.87 151.77 119.60 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 39.90 58.52 Short Term Provisions 32.07 31.32 42.75 53.82 28.20 13.88 15.01 2.23 7.12 0.50 Total Liabilities 9,541.09 8,773.18 7,834.14 6,496.05 4,086.04 3,522.58 2,928.34 2,473.74 2,086.31 1,758.13 Net Block 1,693.73 1,570.55 1,502.19 954.23 968.10 928.74 842.64 871.58 787.88 648.63 Gross Block 2,579.91 2,294.95 2,081.32 1,430.70 1,347.81 1,219.58 1,054.45 1,005.52 1,020.22 820.49 Accumulated Depreciation 886.18 724.41 579.13 476.46 379.71 290.83 211.81 133.94 232.34 171.86 Non Current Assets 4,969.76 1,884.84 1,989.70 1,372.99 1,239.75 1,165.13 1,077.36 1,065.60 1,014.41 902.65 Capital Work in Progress 120.00 177.22 190.75 337.81 188.47 123.16 198.88 161.15 202.10 192.08 Non Current Investment 2,385.74 8.16 8.16 0.55 0.00 0.00 0.00 0.00 0.17 0.17 Long Term Loans & Adv. 768.88 128.92 286.40 77.97 81.52 111.89 33.89 29.42 21.63 54.86 Other Non Current Assets 1.41 0.00 2.21 2.43 1.66 1.33 1.95 3.44 2.62 6.92 Current Assets 4,571.32 6,888.34 5,844.44 5,123.07 2,846.29 2,357.46 1,850.98 1,408.15 1,071.90 855.48 Current Investments 0.00 0.00 154.87 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 1,260.21 1,945.30 1,185.67 1,275.17 756.28 911.88 512.83 378.72 367.08 321.19 Sundry Debtors 1,171.40 862.84 1,074.81 670.97 601.78 506.10 475.21 417.87 350.69 169.31 Cash & Bank 1,598.55 3,767.00 3,085.80 3,005.20 1,325.19 753.35 670.84 533.08 273.23 315.63 Other Current Assets 541.17 90.83 96.75 84.12 163.03 186.13 192.10 78.48 80.91 49.35 Short Term Loans & Adv. 436.41 222.37 246.55 87.60 91.80 131.94 126.45 30.20 36.37 17.71 Net Current Assets 4,157.13 6,158.14 5,262.50 4,610.61 2,487.27 1,824.78 1,472.43 1,154.77 784.61 611.30 Total Assets 9,541.08 8,773.18 7,834.14 6,496.06 4,086.04 3,522.59 2,928.34 2,473.75 2,086.31 1,758.13

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Shareholder's Funds 8,723.84 7,958.72 7,157.62 5,903.24 3,646.24 Share Capital 16.47 16.47 16.43 16.36 15.49 Total Reserves 8,705.99 7,940.59 7,127.95 5,861.46 3,614.26 Non-Current Liabilities 488.60 89.68 93.97 80.31 80.78 Secured Loans 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 106.54 3.26 3.82 3.93 4.07 Long Term Provisions 137.21 0.00 0.00 0.00 0.00 Current Liabilities 1,398.36 729.13 582.02 512.53 359.02 Trade Payables 862.69 587.35 462.85 396.35 249.09 Other Current Liabilities 425.13 109.48 76.42 62.36 81.73 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 110.54 32.30 42.75 53.82 28.20 Total Liabilities 10,610.80 8,777.53 7,833.61 6,496.08 4,086.04 Net Block 3,946.75 1,570.55 1,502.19 954.23 968.10 Gross Block 5,011.68 2,294.95 2,081.32 1,430.70 1,347.81 Accumulated Depreciation 1,064.93 724.41 579.13 476.46 379.71 Non Current Assets 4,965.66 1,876.73 1,981.54 1,372.44 1,239.75 Capital Work in Progress 237.88 177.22 190.75 337.81 188.47 Non Current Investment 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 773.93 128.96 286.40 77.97 81.52 Other Non Current Assets 7.09 0.00 2.21 2.43 1.66 Current Assets 5,645.15 6,900.81 5,852.08 5,123.64 2,846.29 Current Investments 0.00 0.00 154.87 0.00 0.00 Inventories 1,655.24 1,945.30 1,185.67 1,275.17 756.28 Sundry Debtors 1,558.69 871.39 1,074.81 670.97 601.78 Cash & Bank 1,839.43 3,770.68 3,093.44 3,005.75 1,325.19 Other Current Assets 591.80 91.00 96.75 84.15 163.03 Short Term Loans & Adv. 489.19 222.44 246.55 87.60 91.80 Net Current Assets 4,246.79 6,171.68 5,270.05 4,611.11 2,487.27 Total Assets 10,610.81 8,777.54 7,833.62 6,496.08 4,086.04

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 1,135.97 367.89 791.29 604.93 700.93 185.06 201.93 476.46 224.09 148.05 PBT 1,405.50 1,048.40 1,619.04 1,334.85 992.87 686.36 501.56 578.01 459.11 272.43 Adjustment 23.15 37.38 -28.19 17.30 32.15 76.12 50.94 70.69 68.72 56.67 Changes in Working Capital 23.38 -407.00 -393.05 -435.80 -79.94 -353.94 -193.43 -10.86 -187.17 -117.14 Cash after chg. in Working capital 1,452.02 678.78 1,197.80 916.36 945.07 408.53 359.07 637.85 340.66 211.96 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -316.05 -310.89 -406.51 -311.43 -244.14 -223.47 -157.14 -161.39 -116.56 -63.91 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2,923.92 1,208.22 -1,010.23 -1,524.55 -766.08 -314.14 -358.84 -96.65 -11.91 -399.89 Net Fixed Assets -227.74 -200.10 -503.56 -232.23 -193.54 -89.41 -86.66 55.65 -209.75 -239.38 Net Investments -2,377.58 154.87 -162.48 -0.55 0.00 0.00 0.00 0.17 0.00 -0.12 Others -318.60 1,253.45 -344.19 -1,291.77 -572.54 -224.73 -272.18 -152.47 197.84 -160.39 Cash from Financing Activity -7.40 14.92 34.90 1,238.46 -6.87 -2.93 -3.59 -116.42 -92.90 333.48 Net Cash Inflow / Outflow -1,795.35 1,591.04 -184.04 318.84 -72.01 -132.01 -160.50 263.39 119.29 81.64 Opening Cash & Equivalents 1,905.22 311.18 491.92 169.50 236.40 372.84 533.08 273.23 157.81 76.04 Closing Cash & Equivalent 116.20 1,905.22 311.18 491.92 169.50 236.40 372.84 533.08 273.23 157.81

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Cash From Operating Activity 996.80 363.97 790.77 604.93 700.93 PBT 1,132.54 1,054.58 1,618.55 1,334.81 992.87 Adjustment 223.60 38.19 -28.27 17.30 32.15 Changes in Working Capital -53.20 -417.94 -393.01 -435.76 -79.94 Cash after chg. in Working capital 1,302.95 674.83 1,197.28 916.35 945.07 Interest Paid 0.00 0.00 0.00 0.00 0.00 Tax Paid -306.15 -310.87 -406.51 -311.43 -244.14 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -1,756.91 1,208.19 -1,002.62 -1,524.00 -766.08 Net Fixed Assets -227.74 -200.10 -503.56 -232.23 Net Investments -2,377.58 154.87 -162.48 -0.55 Others 848.41 1,253.42 -336.58 -1,291.22 Cash from Financing Activity -799.42 14.92 34.90 1,238.46 -6.87 Net Cash Inflow / Outflow -1,559.53 1,587.08 -176.95 319.39 -72.01 Opening Cash & Equivalents 1,908.89 318.82 492.46 169.50 236.40 Closing Cash & Equivalent 357.09 1,908.89 318.82 492.46 169.50

Financial Ratios

Standalone /

Consolidated

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 546.04 482.80 434.87 359.30 234.25 1847.12 1555.61 1348.70 1082.33 889.58 ROA 11.39% 9.34% 16.92% 18.84% 20.32% 14.01% 11.89% 18.15% 16.31% 13.75% ROE 12.31% 10.28% 18.62% 20.97% 23.81% 17.14% 14.27% 21.97% 20.42% 18.79% ROCE 16.67% 13.97% 24.86% 28.00% 30.68% 26.11% 22.41% 30.04% 28.35% 22.50% Fixed Asset Turnover 1.71 1.65 2.51 2.49 2.05 1.80 1.58 1.47 1.47 1.45 Receivable days 89.08 97.78 72.40 67.08 76.78 87.61 100.43 94.03 69.91 61.50 Inventory Days 140.38 158.00 102.05 107.06 115.61 127.19 100.26 91.25 92.53 114.35 Payable days 88.68 113.93 74.33 96.62 73.57 99.56 79.68 57.64 32.44 46.12 Cash Conversion Cycle 140.78 141.84 100.12 77.52 118.83 115.24 121.01 127.64 129.99 129.73 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.07 0.12 Interest Cover 180.20 142.41 309.98 392.34 139.24 193.80 122.59 91.43 28.97 17.32

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20
Book Value (Rs.) 529.56 483.12 434.84 359.30 234.25 ROA 7.97% 9.40% 16.91% 18.84% 18.91% ROE 9.26% 10.34% 18.61% 20.97% 21.29% ROCE 13.63% 14.04% 24.85% 28.00% 27.39% Fixed Asset Turnover 1.55 1.66 2.51 2.49 1.95 Receivable days 78.29 97.99 72.40 67.08 83.41 Inventory Days 116.00 157.65 102.05 107.06 104.83 Payable days 121.78 113.72 74.35 96.63 52.71 Cash Conversion Cycle 72.51 141.92 100.10 77.51 135.53 Total Debt/Equity 0.04 0.00 0.00 0.00 0.00 Interest Cover 44.23 142.61 309.77 392.33 139.24

Top Investors:

mirae asset large & midcap fund

hdfc mutual fund - hdfc mid-cap opportunities fund

nippon life india trustee ltd-a/c nippon india growth fund

icici prudential india opportunities fund

sbi large & midcap fund

aditya birla sun life trustee private limited a/c aditya birla sun life frontline equity fund

uti flexi cap fund

llp

Annual Reports:

News Update:

Gland Pharma gets USFDA’s approval for Phytonadione Injectable Emulsion
12th Dec 2024, 09:16 AM

The Product is bioequivalent and therapeutically equivalent to the RLD, Vitamin K1 Injectable Emulsion USP, 10 mg/mL, of Hospira, Inc.
Read More
Gland Pharma gets USFDA’s nod for Latanoprost Ophthalmic Solution
3rd Dec 2024, 11:43 AM

This Product is used for the treatment of high eye pressure/intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension
Read More
Gland Pharma reports 16% fall in Q2 consolidated net profit
5th Nov 2024, 11:26 AM

Consolidated total income of the company increased by 2.73% at Rs 1,465.49 crore for Q2FY25
Read More

Gland Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543245 | NSE: GLAND

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Gland Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543245 | NSE: GLAND

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: